Clinical Trials Browser

INDUSTRY × Carcinoma, Non-Small-Cell Lung × Lapatinib × Clear all

NCT00528281 2017-11-17

A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung